Yu.A. Tolkunov, Yu.D. Ignatov

Object of study - a pharmacological agent afobazole related to anxiolytics. Experimental model is the primary afferent peripheral neurons of the guinea pigs. Acetylcholine (Sigma) was used as excitatory neurotransmitter. Methodology is an intracellular recording of the membrane potential. It was found that afobazole (1×10^-9 - 1×10^-7 mol/l) reduced the amplitude of the action potential (AP) induced by acetylcholine (ACh) (1×10^-6 mol/l) in the guinea pigs primary afferent neurons. It was shown that afobazole (1×10^-9 mol /l) reduced the amplitude of the action potential from the initial 73 ± 2 mV to 36 ± 2 mV, corresponding to an effective dose afobazole ED50. Modulating effect of afobazole leads to decrease of the amplitude of AP in the primary afferent neurons.

 

1. Seredenin S.B., Voronin M.V. Nejroreczeptorny'e mexanizmy' dejstviya afobazola // E'ksperimental'naya i klinicheskaya farmakologiya. 2009. T.72. № 1. S. 3 - 11.
2. Tolkunov Ju.A. Sensorny'e nejrony' metasimpaticheskix (intramural'ny'x) gangliev tonkoj kishki morskoj svinki // Rossijskij fiziologicheskij zhurnal im. I.M. Sechenova. 2004. T.90. № 2. S. 221 - 229.
3. Tolkunov Ju.A. Modulirovanie defensinom HNP-1 aktivnosti pervichny'x afferentny'x nejronov tonkoj kishki, vy'zy'vaemoj mediatorami // Texnologii zhivy'x sistem. 2009. T. 7. № 7. S. 29 - 36.
4. Tolkunov Ju.A., Ignatov Ju.D. Moduliruyushhee vliyanie afobazola na potenczialy' dejstviya v pervichny'x afferentny'x nejronax morskoj svinki pri dejstvii serotonina // Texnologii zhivy'x sistem. 2012. T.9. № 10. S. 43 - 48.
5. Tolkunov Ju.A., Sibarov D.A., Frolov D.S. Aktivnost' pervichny'x afferentny'x nejronov tonkoj kishki pri dejstvii gistamina moduliruetsya defensinom HNP-1 // Sensorny'e sistemy'. 2009. T. 23. № 1. S. 79 - 86.
6. Aydar C.T., Palmer C.P., Klyachko V.A. et al. The sigma receptor as a ligand regulated auxiliary potassium channel subunit // Neuron. 2002. V. 34. № 3. P. 399 - 410.
7. Bermack J.E., Debonnel G. The role of sigma receptors in depression // J. Pharmacological Sci. 2005. V. 97. № 3. P. 317 ? 336.
8. Furness J.B., Jones C., Nurgali K. et al. Intrinsic primary afferent neurons and nerve circuits within the intestine // Progr. in Neurobiol. 2004. V. 72. P. 143 - 164.
9. Hayashi T., Su T. Sigma-1 receptor at the ER-mito­chondrion interface regulate Ca2+ signaling and cell survical // Cell. 2007. V.131. P. 596 - 610.
10. Hiranita T., Soto P.L., Kohut S.J. et al. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors // JPET. 2011. V. 339. № 2. P. 662 - 677.
11. Johannessen M., Ramachandran S., Riemer L. et al. Voltage-gated sodium channel modulation by σ-receptor in cardiac myocytes and heterologous systems // Am. J. Cell Physiol. 2009. V. 296. P. C1049 - C1057.
12. Kobayashi T., Matsuno K., Murai M. et al. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain // Neurochemical research. 1997. V. 22. № 9. P. 1105 - 1109.
13. Maurice1 T., Su T. The pharmacology of sigma-1 receptors // Pharmacol. Ther. 2009. V.124. № 2. P. 195 - 206.
14. Morin-Surun M.P., Collin T., Denavit-Sabie M. et al. Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem // Proc. Nat. Academy Sci. USA. 1999. V. 96. № 14. P. 8199 - 8199.
15. Twyman R.E., Rogers C.J., Macdonald R.L. Differential regulation of γ-aminobutyric acid receptor channels by diazepam and phenobarbital // Ann. Neurol. 1989. V. 25. № 3. P. 213 - 220.
16. Su T., Hayashi T., Maurice T. et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator // Trends Pharmacol. Sci. 2010. V. 31. № 12. P. 557 - 566.